For decades, drug development has followed a predictable cadence: run a trial, wait, analyze, submit. Progress has often been defined as much by...
Read PostNews
Stay up-to-date on the latest industry, member, & policy related news.
Share your News
MichBio members can submit news to be shared here, on our social media, and in our monthly newsletter.
Momentum in Congress around Medicare coverage reform for medical devices appears to have slowed following the Administration’s introduction...
Read PostAs the Michigan Senate considers the FY budget for the Department of Health and Human Services, MichBio is raising strong concerns about the...
Read PostMichBio joined leaders from across the country in Washington, D.C. for the 2026 Council of StateBioscience Associations (CSBA) Fly-In, bringing...
Read PostMichigan’s role in the national biosciences economy - and its importance to U.S. biodefense - took center stage on April 10 as the...
Read PostDrug discovery is full of scientific promise but early‑stage discovery remains one of the most resource‑intensive and challenging phases of...
Read PostMichBio seeks a highly motivated individual who can work creatively in a small team environment and assist in data mining, compilation, and...
Read PostPrincipal Scientist - BiophysicsKalamazoo, MI • Full-Time Proteos, Inc. is a wholly owned subsidiary of NanoImaging Services, Inc. (NIS)...
Read PostCongress passed long-awaited legislation to reauthorize the SBIR and STTR programs, sending the bill to President Trump on April 1, 2026, for...
Read PostThe White House this past week announced a sweeping new tariff policy targeting imported patented pharmaceutical products, positioning the move as...
Read PostThe Trump Administration’s FY2027 budget proposal underscores a significant shift in federal priorities—pairing a record $1.5 trillion...
Read PostMichBio’s 2025 Michigan BioIndustry Workforce Trends Report highlights a biosciences sector that is both resilient and evolving, with strong...
Read Post